532 related articles for article (PubMed ID: 12180001)
1. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
László A
Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
[TBL] [Abstract][Full Text] [Related]
2. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
3. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
Jacobsen RB; Phillips BB
Ann Pharmacother; 2004 Sep; 38(9):1469-81. PubMed ID: 15213313
[TBL] [Abstract][Full Text] [Related]
4. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
Lanas A
Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
Wallace JL
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
Agrawal NM; Dajani EZ
Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs.
Wolfe MM
Int J Clin Pract Suppl; 2003 Apr; (135):32-7. PubMed ID: 12723745
[TBL] [Abstract][Full Text] [Related]
11. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
Nishida T; Tsujii M; Tsuji S
Nihon Rinsho; 2004 Mar; 62(3):561-5. PubMed ID: 15038104
[TBL] [Abstract][Full Text] [Related]
12. Inadequate prevention of NSAID-induced gastrointestinal events.
Herings RM; Goettsch WG
Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
14. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
15. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
16. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
18. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
McCarthy DM
J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
[TBL] [Abstract][Full Text] [Related]
19. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Laine L
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
[TBL] [Abstract][Full Text] [Related]
20. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
Naesdal J; Wilson I
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
